115 related articles for article (PubMed ID: 20662318)
21. Doxorubicin loading fucoidan acetate nanoparticles for immune and chemotherapy in cancer treatment.
Lee KW; Jeong D; Na K
Carbohydr Polym; 2013 May; 94(2):850-6. PubMed ID: 23544642
[TBL] [Abstract][Full Text] [Related]
22. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
23. Construction of doxorubicin-loading magnetic nanocarriers for assaying apoptosis of glioblastoma cells.
Wang X; Wang L; Tan X; Zhang H; Sun G
J Colloid Interface Sci; 2014 Dec; 436():267-75. PubMed ID: 25280371
[TBL] [Abstract][Full Text] [Related]
24. Magnetic nanobeads decorated by thermo-responsive PNIPAM shell as medical platforms for the efficient delivery of doxorubicin to tumour cells.
Deka SR; Quarta A; Di Corato R; Riedinger A; Cingolani R; Pellegrino T
Nanoscale; 2011 Feb; 3(2):619-29. PubMed ID: 21082085
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
26. Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy.
Li T; Zhang M; Wang J; Wang T; Yao Y; Zhang X; Zhang C; Zhang N
AAPS J; 2016 Jan; 18(1):146-55. PubMed ID: 26381779
[TBL] [Abstract][Full Text] [Related]
27. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].
Wang JC; Liu XY; Lü WL; Lee HS; Goh BC; Zhang Q
Yao Xue Xue Bao; 2005 May; 40(5):475-80. PubMed ID: 16220797
[TBL] [Abstract][Full Text] [Related]
28. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Eliaz RE; Szoka FC
Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
[TBL] [Abstract][Full Text] [Related]
29. Preparation and anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes: magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense.
Sun JB; Duan JH; Dai SL; Ren J; Guo L; Jiang W; Li Y
Biotechnol Bioeng; 2008 Dec; 101(6):1313-20. PubMed ID: 18980188
[TBL] [Abstract][Full Text] [Related]
30. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
31. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
32. Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin.
Cao Y; Gu Y; Ma H; Bai J; Liu L; Zhao P; He H
Int J Biol Macromol; 2010 Mar; 46(2):245-9. PubMed ID: 19958788
[TBL] [Abstract][Full Text] [Related]
33. Core-shell-corona doxorubicin-loaded superparamagnetic Fe3O4 nanoparticles for cancer theranostics.
Semkina A; Abakumov M; Grinenko N; Abakumov A; Skorikov A; Mironova E; Davydova G; Majouga AG; Nukolova N; Kabanov A; Chekhonin V
Colloids Surf B Biointerfaces; 2015 Dec; 136():1073-80. PubMed ID: 26595387
[TBL] [Abstract][Full Text] [Related]
34. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
35. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
[TBL] [Abstract][Full Text] [Related]
36. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
37. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy.
Zhao Y; Lu Y; Hu Y; Li JP; Dong L; Lin LN; Yu SH
Small; 2010 Nov; 6(21):2436-42. PubMed ID: 20878636
[TBL] [Abstract][Full Text] [Related]
39. Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.
Arai T; Benny O; Joki T; Menon LG; Machluf M; Abe T; Carroll RS; Black PM
Anticancer Res; 2010 Apr; 30(4):1057-64. PubMed ID: 20530409
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
